Peter Horak is a medical oncologist currently employed at the National Center for Tumor Diseases (NCT) Heidelberg since March 2016. Prior to this role, Peter Horak held the same position at Wiener Gesundheitsverbund from March 2013 to February 2016 and served as a research fellow focused on cancer research at the Medical University of Vienna from July 2013 to July 2014. Peter Horak's medical training includes a residency at the Medical University of Vienna from March 2009 to February 2013 and another residency at the Medical University of Vienna from March 2004 to August 2006. Additionally, Peter Horak was a research fellow and instructor in medicine at Harvard Medical School from September 2006 to February 2009. Peter Horak obtained a Doctor of Philosophy (PhD) in Tumor Biology from the Medical University of Vienna and a Doctor of Medicine (MD) from the University of Vienna.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.